Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 808 results for "Treatment For Multiple Sclerosis"

Biogen (BIIB) Stock Surges, But Real Blockbuster Is in the Pipeline
InvestorPlace.com

Biogen Idec Jumps as 2015 Profit Forecast Surpasses Estimates

(Bloomberg) -- Biogen Idec Inc., the maker of multiple sclerosis drugs including Tecfidera and Tysabri, surged in late trading on a 2015 profit forecast that surpassed analysts estimates. Adjusted earnings will reach $16.60 to $17 a share this ... Washington Post, 1 day ago
BIOGEN IDEC : Profit Nearly Doubles 4 Traders, 1 day ago
Biogen's Profit Nearly Doubles iMarketReports, 1 day ago
[x]  

5 images for Treatment For Multiple Sclerosis

Citybizlist, 1 week ago
EMax Health, 4 days ago
Raconteur, 1 day ago
WDTV, 4 weeks ago
Airdrie Echo, 1 week ago
Health Canal

First Canadian Clinical Trial Studying Ability of Mesenchymal Stem Cells to Treat Multiple Sclerosis

The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation announced today a $4.2 million grant in support of the MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS) study led by Dr. Mark S.
 Individual.com1 day ago Media Advisory - Interview and Photo Opportunity: Leading Canadian Researchers to Announce Landmark Study Involving Stem Cells and Multiple Sclerosis  Reuters2 days ago The Ottawa Hospital leads first Canadian clinical trial of mesenchymal stem cell therapy for multiple sclerosis  Health Canal1 day ago Media Advisory -Interview and Photo Opportunity:Leading Canadian Researchers to Announce Landmark Study Involving Stem Cells and Multiple Sclerosis  BioMedReports1 week ago
[x]  
MedIndia

Stem Cell Therapy Scam in Treating Multiple Sclerosis

A client of Winnipeg-based Company has claimed the company to be fraudulent, as it had publicised its ability to improve the lives of Multiple Sclerosis patients through stem cell therapy. The CEO of Regenetek Research Inc for treatment collects ...
 MedIndia1 week ago
Raconteur

1 Understanding multiple sclerosis

WHAT IS MS? Multiple sclerosis (MS) is a neurological condition that damages the central nervous system. The body's immune system attacks and degrades a fatty tissue coating, called myelin, that surrounds and protects the nerve fibres of the brain ...
 Raconteur1 day ago Study reveals new challenges faced by MS patients  Easier1 day ago Research into MS and other health conditions published  Multiple Sclerosis Trust1 day ago IgE-Mediated Allergic Reactions after the First Administration of Glatiramer Acetate in Patients with Multiple Sclerosis  Karger.com3 days ago
[x]  

Manitoba funds treatment with AUBAGIO for Relapsing Remitting Multiple Sclerosis

Canada NewsWire MISSISSAUGA, ON, Jan. 16, 2015 Once-daily oral medication to be reimbursed for first-line use MISSISSAUGA, ON AUBAGIO is indicated as monotherapy for the treatment of RRMS to reduce the frequency of clinical exacerbations and to ...
 Digital Journal2 weeks ago U.S. FDA approves Sanofi's MS drug Lemtrada  Reuters2 months ago
[x]  

Jan. 21: Bisphenol A research, multiple sclerosis treatment

Food safety watchdog in Europe is countering findings that Bisphenol A, a chemical used to make plastic, is harmful to your health Researchers say stem cells could provide new treatment options for reversing the disability caused by multiple ...
 660 News1 week ago

Oxygen treatment professor to give talk

Today by Alice Mascarenhas With plans to expand the Multiple Sclerosis Therapy Centre on the Rock, Professor Philip James with 32 years experience in the field, is in Gibraltar to consult and advice on the possible changes locally. Whilst ...
 Gibraltar Chronicle1 week ago
Metro Canada

Stem cells partially reverse disability in small MS trial

An early clinical trial investigating a new form of stem cell therapy for multiple sclerosis (MS) has demonstrated neurological improvement and enhanced quality of life for patients. The research, published in JAMA , suggested reversal of some of ...
 BioNews4 days ago Ottawa, Winnipeg researchers to test stem cell treatment on MS patients  Metro Canada1 day ago Genuine MS clinical trial approved for Manitobans [Winnipeg Free Press (Canada)]  Pharmacy Choice4 hours ago Ottawa doc to embark on groundbreaking MS study  Sun News1 day ago
[x]  

Biogen Idec Inc Earnings: Worth the Wait

Going into the release, there was worry that growth of Tecfidera, Biogen's oral multiple sclerosis drug, was slowing down, especially in the U.S., but that doesn't really seem to be as big of a problem as investors feared. There was one extra ...
 Motley Fool1 day ago

Google Inc (GOOG) And Biogen Idec Inc Join Hands For Multiple Sclerosis Research

Google Inc ( NASDAQ:GOOG ), with plans to expand into medical research, has decided to team up withBiogenIdecInc ( NASDAQ:BIIB ), one of the world's leading biotechnology companies, to explore the biological as well as environmental causes leading ...
 Bidness Etc3 days ago Google, Biogen Seek Reasons for Advance of Multiple Sclerosis  BusinessWeek4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less